Vyne Therapeutics Inc (NASDAQ:VYNE)
| 0.2386 Delayed Data As of Sep 28 |  +0.0125 / +5.53%Today’s Change | 0.23 Today|||52-Week Range 1.75 | -76.61% Year-to-Date |
Latest VYNE News | Press Releases
No recent news for Vyne Therapeutics Inc.
Today’s Trading
| Previous close | 0.23 |
| Today’s open | 0.24 |
| Day’s range | 0.24 - 0.24 |
| Volume | 236 |
| Average volume (3 months) | 334,629 |
| Market cap | $13.9M |
Data as of 3:55pm ET, 09/28/2022
Growth & Valuation
| Earnings growth (last year) | +81.93% |
| Earnings growth (this year) | +62.70% |
| Earnings growth (next 5 years) | -53.49% |
| Revenue growth (last year) | -29.71% |
| P/E ratio | NM |
| Price/Sales | 3.56 |
| Price/Book | 0.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PLXPPLx Pharma Inc | +0.04 | +7.94% |
| ---- | ||
| ARDSAridis Pharmaceutica... | +0.11 | +15.67% |
| KBPHKyto Technology and ... | 0.00 | 0.00% |
Data as of 3:59pm ET, 09/28/2022
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $14.8M |
| Annual profit (last year) | -$73.3M |
| Net profit margin | -496.98% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
